08/04
Headlines

Kristen Barton

Kristen Barton is a managing director and co-director of investment research. Kristen is also a senior research analyst focusing on agriculture & biotech companies. Prior to joining Tech Insider in 2010, Barton worked in equity research at RBC Capital Markets in Minneapolis, MN and Edward Jones in St. Louis, Mo. She was recognized for her stock picking in the 2012 Wall Street Journal "Best on the Street" publication.

Today’s Watch List: Denbury Resources Inc. (NYSE:DNR), Kinross Gold Corporation (NYSE:KGC), Science Applications International Corporation (NYSE:SAIC), AT&T, Inc. (NYSE:T), Hill-Rom Holdings (NYSE:HRC)

Kristen Barton03 mins

Denbury Resources Inc. (NYSE:DNR) SVP James S. Matthews sold 6,000 shares of the company’s stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $15.99, for a total value of $95,940.00. Following the sale, the senior vice president now directly owns 73,473 shares in the company,…

Read More

Stocks to Watch : Mitsubishi UFJ Financial Group, Inc. (NYSE:MTU), Arrowhead Research Corp. (NASDAQ:ARWR), Tesla Motors (NASDAQ:TSLA), Magellan Health, Inc. (NASDAQ:MGLN), IBM

Kristen Barton03 mins

On Monday, MUFG Union Bank, N.A., a prime member of Mitsubishi UFJ Financial Group Inc. ( MTU ) announced a strategic affiliation with a business unit of Guggenheim Partners – Guggenheim Investment Advisory (GIA). Through this partnership, MUFG Union Bank will provide world-class alternative investment solutions to its customers with the help of the Guggenheim…

Read More

Second Quarter Profits Rise for STI

Kristen Barton02 mins

Second-quarter profits to common investors at SunTrust Banks rose 35% to $365 million, or $0.68 a diluted share, from $270 million, or $0.50 a diluted share, a year earlier. Net interest income fell 5% to about $1.2 billion, as reported net interest margin fell to 3.25% from 3.39% in 2012’s second quarter. However, SunTrust’s earnings…

Read More

Stocks in Focus: BIND Therapeutics, Inc. (NASDAQ:BIND), Bristol-Myers Squibb Company (NYSE:BMY), TC PipeLines, LP (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Kristen Barton03 mins

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in…

Read More

Ormat’s Continued Efficiency Yields Impressive Q2 Results

Kristen Barton02 mins

‘ second-quarter earnings demonstrate the strength of the company’s business model and underlying profitability, as highly efficient and productive new plants drove improvement in the electricity segment and the company’s dominance in lower-heat geothermal continued to produce strong results. During the quarter, Ormat earned $0.41 per share excluding noncash derivative gains and the gain on…

Read More

Trader’s Watch List : Newmont Mining Corporation (NYSE:NEM), Regions Financial Corporation (NYSE:RF), Fabrinet (NYSE:FN), CBD Energy Limited (NASDAQ:CBDE), United Technologies Corporation (NYSE:UTX)

Kristen Barton03 mins

Equities researchers at Deutsche Bank dropped their target price on shares of Newmont Mining Corp (NYSE:NEM) from $27.00 to $25.00 in a research report issued on Thursday. The firm currently has a “hold” rating on the stock. Deutsche Bank’s price target would indicate a potential upside of 8.65% from the stock’s previous close. Newmont Mining…

Read More